Proposal summaries
B1486 - Phthalates Asthma and Obesity in a Large Longitudinal Cohort - 17/01/2013
Asthma and obesity are two of the most common chronic and disabling conditions of childhood. While both are multifactorial (risk factors include genetics, race, socioeconomic status, diet, and physical activity), most of these risk factors are not amenable to modification or avoidance. However, environmental factors are amenable to change and are plausible contributing factors to both. Given documented rapid increases in both conditions over the past three decades, it is imperative to find ways to reduce both asthma and obesity.
Phthalates, chemicals used to produce a diverse array of consumer products including shampoos, plastic bottles and cosmetics, have been found to interact withperoxisome proliferator-activated receptors that play critical roles in lipid and carbohydrate metabolism.Di-2-ethylhexylphthalate (DEHP) is of particular concern, because mono-(2-ethylhexyl) phthalate,a DEHP metabolite,increases expression of threeperoxisome proliferator-activated receptors(PPARs) which play key roles inlipidand carbohydrate metabolism, providing biological plausibility for a role of DEHP metabolites in childhood obesity and insulin resistance. Additionally, DEHP metabolites induce the release of pro-inflammatory cytokines from lung cells, and activation of PPARs can also modulate immune response.
Investigators have found associations of exposure to plastic wall materials with the development of bronchial obstruction, persistent wheeze, cough, and phlegm in children.Prenatal exposure to butylbenzylphthalate, a high molecular weight (HMW) phthalate used in flooring, has been associated with the development of eczema in one urban longitudinal birth cohort, and a cross-sectional study has associated urinarymono-carboxyoctyl phthalate and mono-carboxynonyl phthalate with asthma.Cross-sectional studies and one longitudinal cohort study have associated lower-molecular weight phthalates with child and adolescent obesity. It is plausible that fetal vulnerability to DEHP is greater, and that this earlier life exposure is more likely to disrupt endocrine processes that maintain dietary balance, leading to obesity. Measurement of phthalates at a single timepoint in pregnancy has moderate sensitivity (56-67%) and high specificity (83-87%) for four phthalate metabolites to estimate exposure tertile over a three-month period, but past studies have been unable to assess a developmental window of vulnerability to phthalate exposure.
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a longitudinal population-based birth cohort study of 14,541 UK mothers enrolled during pregnancy in 1991 and 1992, with data collected at multiple time points during pregnancy and in childhood, through review of hospital records, clinical and laboratory examination, and surveys of parents and children.This population is well-characterized with regard tosociodemographic and behavioral risk factors for obesity, and represents an efficient method to examine ubiquitous environmental chemical exposures as separate risks. We propose to analyze 1500 banked maternal urine samples from each of three trimesters of pregnancy for urinary phthalates, and assess associations with standardized measures of infant, child and adolescent body mass, allergy, and respiratory outcomes.
Aim 1. To examine whether prenatal urinary phthalate metabolites are associated with weight-for-length and Body Mass Index Z-scores in childhood, fat mass, and cardiovascular risks in the school age years and adolescence.
H1. Prenatal urinary phthalates are independently associated with increases in standardized measures of body mass and obesity in childhood, as well as increases in fat mass, adjusting for maternal, sociodemographic and other lifestyle factors.
Aim 2. To examine whether prenatal urinary phthalate metabolites are associated with wheeze, allergy, and asthma phenotype in childhood.
H2a. Prenatal urinary phthalates are associated with increased odds of wheeze in children, adjusting for potential confounding factors.
H2b. Prenatal urinary phthalates are associated with increased odds of allergic phenotype (eczema, rhinitis, or allergy) in children, adjusting for potential confounding factors.
H2b. Prenatal urinary phthalates are associated with asthma phenotype (asthma diagnosis or bronchodilator responsiveness) in children, adjusting for potential confounding factors.
Aim 3. To examine whether prenatal urinary phthalate metabolites are associated with decrements in pulmonary function in the school-age years.
H3. Prenatal urinary phthalates are independently associated with decrements in pulmonary function (forced expiratory volume in the first second (FEV1) and the ratio of FEV1 to forced vital capacity.
B1485 - The influence of breathing disorders on face shape - 17/01/2013
Aims: To explore the effect of breathing disorders including asthma, atopy allergic rhinitis and sleep disordered breathing on face shape at age 15 years and to evaluate the effect of adenoidectomy and tonsillectomy on face shape.
Hypothesis: Breathing disorders, adenoidectomy and tonsillectomy have no effect on face shape in late adolescent.
Background: Respiratory activity may have an influence on craniofacial development and interact with genetic and environmental factors. It has been suggested that certain medical conditions such as asthma have an influence on face shape. Altered mechanics of breathing may influence the development of craniofacial structures and tends to result in significant changes in face shape particularly increased face height and retrusive mandible. However, removal of adenoids and tonsils has been reported to have a significant effect on obstructive breathing and if conducted early will normalize dentofacial morphology. ALSPAC provides the opportunity to explore a longitudinal data set with detailed facial morphology measures in late childhood on a large, representative sample.
Three-dimensional laser surface facial scans were obtained. Differences in the twenty-one reproducible facial landmarks (x, y, z co-ordinates) for the various groups will be evaluated as well as average facial shells will be created for asthmatic, atopic allergic rhinitis, sleep disordered breathing and healthy controls to explore surface differences.
Study design: observational longitudinal cohort study.
Confounding factors: height, weight, BMI, pubertal status.
Freeman K, Bonuck K 2012 Snoring, mouth-breathing, and apnea trajectories in a population-based cohort followed from infancy to 81 months: a cluster analysis. International Journal of Pediatric Otorhinolaryngology 76: 122-30
Jefferson Y 2010 Mouth breathing: adverse effects on facial growth, health, cademics and behavior. General Dentistry 58: 18-25
Wenzel A, Hojensgaard E, Henriksen J M 1985 Craniofacial morphology and head posture in children with asthma and perennial rhinitis. European Journal of Orthodontics 7: 83-92
Zettergren-Wijk L, Forsberg C M, Linder-Aronson S 2006 Changes in dentofacial morphology after adeno-/tonsillectomy in young children with obstructive sleep apnoea--a 5-year follow-up study. European Journal of Orthodontics 28: 319-26.
B1484 - Post natal depression - GWAS meta-anaylsis and allelic risk scores - 17/01/2013
AIMS:
1) To perform a genome-wide association study (GWAS) of postnatal depression (PND)
2) To investigate whether the power to detect PND is improved by incorporating information from nominally significant SNPs in a polygenic risk score
HYPOTHESIS:
1) We hypothesise that common variants contribute to the susceptibility to PND, and that a meta-analysis of GWAS studies can identify regions containing variants relating to this trait.
2) Additionally we hypothesise that our ability to predict PND will be improved by increasing the SNPs included in a genetic risk score, even if they do not achieve genome-wide significance.
VARIABLES:
The outcome variable will be PND case-control status. Women will be classified as cases or controls based on their score in the Edinburgh Postnatal Depression Scale (EPDS) measured 8 weeks postpartum. For the profile scoring, the exposure variable will be the polygenic risk score as calculated from the imputed genotype data available for mothers in ALSPAC. Association results from the Psychiatric Genetics Consortium meta-analysis of bipolar disorder (PGC-BPD) will be used to determine the SNPs to be included in the risk score. Several versions of this risk score will be computed using p-value thresholds of varying stringency (pless than 0.001, 0.01, 0.05, 0.1, 0.5, all SNPs) for inclusion in the score. Ancestry principle components will also be adjusted for.
METHODS:
Mothers enrolled in the ALSPAC cohort who have contributed genetic data to the study, and on whom we have information relating to postnatal depression at 8 weeks postpartum, will be used as the study sample.
We will perform a GWAS using the binary PND variable, and these results will be meta-analysed together those from previous GWAS studies. Polygenic risk scores will be derived using the clumped association results available from the PGC-BPD study. A number of p-value thresholds will be used to determine which of these SNPs to include in the risk score for PND.
Women will be classified as cases or controls based on their score in the Edinburgh Postnatal Depression Scale (EPDS) measured 8 weeks postpartum. A logistic regression model will be constructed, including the risk score and adjusting for both ancestry principle components and season of birth. Each version of the risk score will be incorporated into this model in turn to distinguish between PND cases and controls.
Participants will be excluded from the analysis either if they have a history of BPD or if they experienced a stillbirth or early neonatal death (within 27 days).
B1482 - Using Mendelian Randomisation to clarify the causal relationship between tobacco use and other substances - 03/01/2013
Aims:
To assess the theory of the Gateway Hypothesis, whereby the use of substances such as tobacco and alcohol ('Gateway Drugs') are a risk factor for the use of harder drugs such as cannabis, cocaine and opiods.
Hypotheses:
The hypotheses of this project can be subdivided into three phases:
1. Assessment of the relationship between patterns of smoking and patterns of alcohol consumption in adults. These hypotheses will be tested using the MR technique, where patterns of smoking can relate to either daily cigarettes smoked or short-term smoking cessation.
2. Assessment of the relationship between patterns of smoking and patterns of alcohol consumption in adolescents. This hypotheses will be tested used either standard epidemiological techniques or Mendelian randomisation.
3. Assessment of the relationship between cannabis and other illegal substances. These hypotheses will be tested using hair sample data taken from adolescents.
There is also scope for further analysis linking hypotheses 1 and 2 with that of 3; however this will be assessed at a later date when preliminary results have been obtained.
The following exerpt it taken from the proposal written in application of the PhD studentship for which this research is a part of and will explain all variables being used in the study:
Phase 1 - Relationship between smoking and alcohol in adults
SNP rs1051730 has been shown to be causally related to both heaviness of smoking and smoking cessation in adults. With this in mind, I propose to use the data collected from the mothers in the ALSPAC cohort in order to use MR to assess both the relationship between heaviness of smoking and alcohol consumption and smoking cessation and alcohol consumption. With regards to heaviness of smoking, the exposure variable used will cigarettes smoked per day in the sample of those who smoke, and for smoking cessation, smoking status before and during pregnancy. The outcome variable used for alcohol consumption will focus on heaviness of use.
Once observational epidemiology has been used to initially assess the relationship between tobacco and alcohol, the relationship between genotype and smoking status will be tested using a model with and without interaction terms between the two variables, using a likelihood ratio test. The relationship between genotype and alcohol consumption will also be tested in this manner in order to show whether the genotype is associated with alcohol consumption independently of smoking status. The effect of both heaviness of smoking and smoking cessation on alcohol consumption will be assessed using instrumental variable estimation by performing a two stage least squares under an additive model. This method will first fit the regression of the exposure (smoking) on the instrument (genotype) before the outcome (alcohol) is regressed on the predicted values of continuing smoking, where the estimate of the causal effect will be the coefficient produced. I will also test whether there is a direct effect of genotype on alcohol consumption in non-smokers.
Phase 2 - Relationship between smoking and alcohol in adolescents
To further the work undertaken in phase1 of this research, the relationship between heaviness of smoking and alcohol consumption and adolescents will be assessed using the ALSPAC child based questionnaires and interviews. As a current genetic signal for smoking in adolescence is not known, this work will explore the availability of a polygene risk score for use with MR, or use a standard epidemiological technique of this is unavailable. The exposure and outcome variables used for this section of analysis will be smoking initiation and heaviness of alcohol use.
The first stage of this analysis will be to gather cross sectional studies that have included the rs1051730 across a range of ages in order to assemble a longitudinal map of the effect of this variant, as has been previously done with the FTO gene.
If a genotypic signal is available for use in this analysis then statistical methods for the rest of the phase will be as for phase 1, however if a standard epidemiological method is applied then multinomial logistic regression will be used with smoking as the exposure and alcohol as the outcome with confounding from environmental factors taken into account.
Phase 3 - Relationship between cannabis and illicit drugs in adolescents
Finally, the relationship between cannabis use and the use of other substances as described in the Gateway Hypothesis will be assessed in ALSPAC adolescents using drug information obtained from hair samples. The hair samples can be used in one of two ways: (1) to validate the self report measures taken from the ALSPAC adolescents and (2) to use the information provided by the hair samples itself. With regards to the first option, this method will be used in assessment of cannabis, as hair samples are only able to provide information of regular or heavy use in relation to this drug. The hair sample analysis for other drugs is more sensitive than for cannabis, meaning that this data can both be used on its own and to validate the self report measures, therefore, for this section of the analysis we will use the biological marker as the outcome. As hair samples were not taken from all members of ALSPAC, this section of the study will have a smaller sample size than others; however, the loss of power from the biological marker will be made up for by increased precision and lack of bias. In order to link this with previous phases, cotinine levels of each of the ALSPAC adolescents will also be used to assess the relationship between tobacco and cannabis, ecstasy, cocaine, amphetamines and heroin.
Standard epidemiological statistical methods will be used here, with cannabis use from self reported questions (validated by hair sample data) as the exposure and the use of other illicit substances as shown by hair samples as the outcome.
Analysis:
All analysis will be undertaken by University of Bristol staff (Michelle Taylor) with Glyn Lewis, Matthew Hickman and Marcus Munafo acting as PhD supervisors.
B1483 - DXA project - 20/12/2012
There is a DPhil computer science student from Oxford University on secondment to a commercial company who may be able to automate our novel method for measuring spinal curvature from total body DXA scans. We developed this method as part of the BSRF-funded ALSPAC project B727, and the method has been submitted for publishing and has been presented in abstract form so is in the public domain.
B1481 - Explaining the association between socioeconomic status and cognitive growth in childhood - 20/12/2012
Differences in cognitive ability determine developmental trajectories across the lifespan, affecting socioeconomic, psychological, and health outcomes. Children from disadvantaged socioeconomic status (SES) families show lower cognitive ability and reduced cognitive growth (i.e. ability gains over time) compared to their high SES peers. However, the mechanisms that underlie the SES-growth association are not fully understood. The proposed research investigates how and to what extent 3 aspects of children's lives - (1) dietary patterns, (2) preschool experiences, and (3) activity engagements - account for SES-related growth differences.
(1) Dietary Patterns. Diets directly impact cognitive function because they are the main source for micronutrients (e.g. vitamins and antioxidants) that enable enzymatic reactions and neurotransmitter synthesis in the brain. However, several diet characteristics have rarely been addressed in research, for example meal types (e.g. snack), times (e.g. breakfast), and preparation method (e.g. prefabricated). Likewise, no previous research has looked at the influence that children's drinking habits (e.g. milk, sugary drinks) may have for cognitive development.
(2) School Experiences. SES-related differences in primary school performance tend to increase or at least persist over time, with disadvantaged children continuing at lower quality secondary schools and obtaining fewer educational qualifications. Preschool attendance may reduce this achievement gap because it provides disadvantaged children with better learning environments than they receive otherwise. The benefits of preschool have not been studied in Britain, where several preschool types exist (e.g. nursery or childcare centre).
(3) Activity Engagement: The availability of activity engagement opportunities, for example music lessons or sport clubs, leads to better primary school achievement16 and is thought to benefit children's cognitive growth. High SES families encourage more frequent and diverse activity participation than do low SES families in the United States16 but these findings have yet to be replicated in Britain. Also, it is unclear if it is the quantity, quality or type of activity engagement that make the difference for children's cognitive development.
Methods: Data will be synchronized across 4 longitudinal, British cohort studies, including the British Cohort Study 1970 (BCS), the Growing Up in Scotland study (GUS), the Millennium Cohort Study (MCS), and the Avon Longitudinal Study of Parents and Children (ALSPAC). The cohorts comprise of large samples, representative of the British population, and span generations from 1970 to 2005 (Table 1). Thus, they allow for (1) exploring and (2) replicating effects of dietary patterns, preschool experiences and activity engagements (herein variable complexes) on cognitive growth, as well as for (3) analyzing possible generation-specific effects. In each cohort study, participants were assessed at least 3 times on cognitive ability, enabling (4) latent growth curve modelling of ability trajectories. They also completed several, mostly repeated measures for all variable complexes, permitting (5) in-depth investigations of their characteristics and continuity over time.
B1480 - Investigation of fascin-2 and associated components of hair cell stereocilia in relation to ALSPAC hearing data - 20/12/2012
Aim.
To investigate whether genetic polymorphisms/mutations in the FSCN2 gene, or in genes encoding proteins known to be present in hair cell stereocilia and associated physically or functionally with fascin-2 protein, are correlated with early-onset hearing loss within the ALSPAC study population.
Hypotheses
1. The human population includes mutations/polymorphisms in FSCN2 that are associated with early-onset hearing loss.
2. The human population includes mutations/polymorphisms in genes encoding proteins that are linked physically or functionally with FSCN2 for assembly and mechanotransduction by stereocilia of hair cells, that are associated with early onset hearing loss.
Rationale
The hair cells of the inner ear have essential roles in mechanotransduction of sound waves into intracellular signals that result in nerve cell impulses. Crucial to mechanotransduction are the hair bundles on the apical surfaces of hair cells. These are made up from many actin-rich stereocilia, fine projections of the cell surface that are made rigid by a central bundle of cross-linked actin filaments. It has recently become appreciated that major components of a protein complex (tip complex) located at the tip of stereocilia are important for gating ion channels in response to mechanical movements of the stereocilia, and that function-perturbing mutants in multiple members of the the tip complex lead to deaf/blindness syndromes such as Usher syndrome (Bonnet and El-Amraoui, 2012). An example of one of these proteins is cadherin-23. Mis-sense mutations in cadherin-23 are also associated with non-syndromic deafness (Schultz et al., 2011). The range of phenotypes associated with cadherin 23 mutations suggest that additional interactions between components of the stereocilia and potential genetic associations with early-onset hearing loss remain to be discovered.
Fascin-2 is an actin-crosslinking protein that until recently was considered to be located specifically in photoreceptor cells of the retina (Lin-Jones and Burnside, 2007; Hashimoto et al., 2011). New data demonstrate that fascin-2 is a component of inner and cochlear hair cell stereocilia in humans, mice and fish (Shin et al., 2010, Chou et al., 2011). Furthermore, studies of very early onset hearing loss (phenotype: increased 16kHz hearing threshold by 5 weeks of age) in the inbred DBA/2J strain of mice have identified a casual role for a mutant variant of fascin-2, fascin-2R109H, in synergy with a mutation in cadherin-23 (Johnson et al., 2008, Shin et al., 2010). This phenotype of these mice can be rescued by transgenesis of wild-type fascin-2 (Shin et al., 2010).
Many SNPs, including multiple non-synonymous coding single nucleotide polymorphisms (SNPs) have been identified in human FSCN2 (NCBI SNP database). Thus a major goal of this pilot study is to identify if any polymorphism in human FSCN2 is associated with early onset hearing loss. We will also examine possible contributions of fascin-2 associated proteins. The large ALSPAC cohort of children who have had hearing measurements taken, including the very sensitive measurements of 16kHz audiometry and otoacoustic emissions and tympanometry variables for middle ear function, can enable us to address this question.
Design
1. The first hypothesis we will test is that SNPs in human FSCN2 and CAD23 are associated with early onset hearing loss in humans, with emphasis on results of extra-high frequency audiometry and otoacoustic emissions, but also including tympanometry variables for middle ear functions.
2. Secondly, we will examine for possible associations of SNPs in genes that encode other proteins of the stereocilia that associate physically or functionally with fascin-2 or cadherin-23. These will include:
-protocadherin-15, that acts with cadherin-23 in the tip links of the tip complex
-other actin crosslinking proteins that are present within stereocilia, as determined by proteomic analyses of isolated stereocilia (plastin-1 as the second most abundant cross-linker, also espin, plastin-2, plastin-3, fascin-1, espin-like protein and xin-related protein 2) (Shin et al., 2010)
-the ion channel HCN2, reported in a biochemical study to associate physically with fascin-2 in cochlear hair cells (Ramakrishnan et al., 2012)
-the human orthologues of six gene products from a candidate interval on mouse chromosome 18 that appears to account for broader spectrum, low frequency hearing losses that occur in the DBA/2J mouse strain by 2-3 months of age (Nagtegaal et al., 2012). The syntenic region of the human genome is 18q21.1 and the six genes are all conserved in this region (NCBI Genes database); MYO5B, ACAA2, c18orf32, DYM, SMAD7 and CTIF
Associations will be examined for each individual gene, and we will also examine if any coding or other SNPs identified occur in the same individual as any SNPs identified in fascin-2 or cadherin-23.
3. To make these analyses, we request access to all SNPs examined within the children in the ALSPAC hearing data studies for the following genes:
Priority 1:
FSCN2
CDH23
HCN2
PCDH15
PLS1
Priority 2:
ESPNL
FSCN1
PLS2
PLS3
XIRP2
MYO5B
ACAA2
c18orf32
DYM
SMAD7
CTIF
References
Bonnet C, El-Amraoui A. (2012) Curr Opin Neurol. 25:42-9.
Schultz, JM et al. (2011) J Med Genet. 48:767-75
Lin-Jones J, Burnside B. (2007) Invest Ophthalmol Vis Sci. 48:1380-8.
Chou SW et al. (2011) PLoS One. 2011;6(4):e14807
Johnson KR et al. (2008) Genomics 92: 291-225.
Shin JB et al., (2010) J. Neurosci 30: 9683-94.
Hashimoto, Y, Kim DJ and Adams, JC (2011). J. Pathology 224:281-300.
Ramakrishnan NA et al (2012) J Biol Chem. 287:37628-46.
Nagtegaal AP et al. (2012) Genes Brain Behav. 2012 Sep 18. doi: 10.1111/j.1601-183X.2012.00845.x.
B1478 - The epidemiology of acne vulgaris - 06/12/2012
Introduction
Conducting an epidemiological study into acne using the ALSPAC study would give us a sound basis to identify further candidate exposures for development into further provocation/prevention studies. We will have strong patient and public involvement in this study to help us disseminate results and prioritise future research.
Aims
1. To study general descriptive epidemiology of acne in ALSPAC including prevalence and severity by age, sex and ethnicity using cross-sectional analyses.
2. To study the determinants of acne incidence (especially dietary factors) using longitudinal approaches
3. To study the natural history of acne e.g. the difference between those with acne early in adolescence compared to those in late adolescence using linked data from successive skin examination sweeps
4. To study the determinants of severe/persistent disease (especially dietary factors)
5. To study the consequences of having had acne such as rates of depression and time off school
Hypotheses for analytical aspects
There is an association between diet and obesity and acne onset.
The risk of severe and persistent acne is increased in those individuals with a high glycaemic index diet in late childhood and after acne has appeared.
Exposure variables
Questionnaire data via food frequency questionnaires on diet collected at 4 weeks, 6, 15, 24, 38, 54, 81, and 103 months and 13 years
Food diaries collected as part of children in focus as well as at the hands on clinics. (Three day diaries)
Food diaries collected at 4, 8, 18, 43 and 61 months and 7.5, 10.6 and 13.9 years.
We are seeking advice from a nutritional epidemiologist who is familiar with ALSPAC to develop appropriate compound variable and a suitable analysis strategy
Demographic data on those who took part in the study
Questionnaire data on other epidemiological data for example, stress and obesity
Outcome variables
Acne severity (from examined skin). Open comedones, closed comedones, red papules, pustules, nodules, fine, superficial/atrophic macular scars, deep ice pick scars, hypertrophic scars, keloid scars and any pigmentary changes were all graded on the face and chest into a few, moderate and many. The presence of acne on the back and shoulders and upper arms/buttocks and thighs was also noted but not graded. Overall, acne severity was graded as trivial, mild, moderate and severe.
Sebutape measurements if available (there may only be a few of these available in Leeds we are currently liaising with Dr. Anne Eedy who is assisting us in our search for them)
Variables that help to document the morbidity associated with having acne such as depression and time off school
Confounding variables
Age, sex, social class
Funding (not yet awarded)
1 NIHR (application closing date 16/1/13)
2 Wellcome (application closing date 08/02/13)
Our analysis of ALSPAC data, if granted, will allow us to test some hypotheses with two other cohort studies - the National Child Development Study and the 1970 British Cohort Study. Although the quality of acne data from these cohorts is limited (some examined acne data in the NCDS and only reported acne data in BCS70) they nevertheless allow some potential verification of findings generated from the rich ALSPAC study.
B1477 - A life-span approach to understanding risk gene contributions to Alzheimers disease - 06/12/2012
Aims:
A. To identify early functional and vascular brain imaging changes in individuals at increased risk of developing Alzheimer's disease (as measured by the presence of risk genes in their DNA, in particular APOE)
B. To understand how any such difference might relate to potential cardiovascular and inflammatory processes, such as disrupted cholesterol transport and elevated pro-inflammatory cytokine production
Hypotheses:
Functional MRI: The APOE epsilon4 group will show increased activation for scenes, but not other conditions, in PCC on all experimental tasks. This difference will be greatest in conditions where there is increased cognitive demand (e.g., longer delays between repeats of stimuli). During learning to discriminate scenes, the difference between carriers and non-carriers will lessen as cognitive 'effort' reduces (and the need for compensatory mechanisms diminishes). In terms of allele risk combination, we predict that, during spatial tasks, activity will show the following pattern: 'epsilon4, epsilon4' greater than 'epsilon3, epsilon4' greater than 'epsilon3, epsilon3' = 'epsilon2, epsilon4' greater than 'epsilon2, epsilon3'.
Vascular Imaging: We predict increased baseline CBF in PCC, elevated 1H MRS metabolite levels, and an increased task-induced increase in CBF. Based on findings in MCI, we also hypothesize a reduced vascular reactivity to carbon dioxide in PCC.
Inflammation and Immunity: Studies in AD predict that, if there are carrier/non-carrier differences, carriers will show higher levels of cholesterol, high sensitivity CRP and IL-6.
Sample:
Based on power calculations we wish to test male (n=125) and female (n=125) participants in their early twenties, who are MRI-compatible. We will use ALSPAC's whole genome data to sort these individuals into five separate APOE groups (n=50 in each group) based on genotype status (e.g., 'epsilon4, epsilon4', 'epsilon3, epsilon4','epsilon3, epsilon3', 'epsilon2, epsilon4' and 'epsilon2, epsilon3', ordered by risk of developing Alzheimer's disease from high to low). This will support two different analyses: (a) comparisons between carriers (n=100, 'epsilon4, epsilon4', 'epsilon3, epsilon4') and 'non-carriers (n=100,'epsilon3, epsilon3', 'epsilon2, epsilon3'), consistent with our earlier study, and (b) investigation of differing brain responses based on allele combination risk profile, in particular whether epsilon2, even in combination with epsilon4, is protective (n in each group = 50). The size of this sample will also allow us to look at our Alzheimer's disease risk genes (e.g., clusterin, ABCA7) in which functional neuroimaging hyper-activity has been documented, as well as undertake polygenic analyses using weighted multiple gene analysis.
Participants will be allocated to blinded research groups prior to visiting the Cardiff University Brain Research Imaging Centre (CUBRIC) on two separate occasions (lasting 3 hours). These sessions would involve imaging (both times), blood and urine sample collection (for additional genotyping (if required), measurement of cholesteol, insulin, high-senstivity CRP, prostaglandins and other inflammatory markers), an exercise challenge and some behavioural testing (see below).
Our participants will also complete validated questionnaires measuring physical activity, general health, and diet and eating styles. We will also measure BMI and blood pressure, and they will undertake an exercise challenge to measure overall fitness. This will be complemented by data from the cohort already collected by ALSPAC researchers. For example, as part of measuring potential cardiovascular health differences, we wish measures of height, weight, fat and lean mass, BMI, fitness, physical activity, resting BP and pulse, BP after exercise and various dietary and food questionnaires. We also require information about potential immune illnesses, such as asthma, eczema and diabetes and have asked for the child-based questionnaire 'Wellbeing of my teenage son/daughter (TB)' allowing us to obtain information on this. We have requested two IQ measures so we can co-vary out any IQ differences across groups, as well as measures of depression (MFQ), mental health (CIS-R).
Outcome variables:
The primary independent variable is regional task-related activity in fMRI. Predictor is risk gene status (known APOE, other genes less clear), with biological measures (e.g., cardiovascular health, cholesterol, cytokines) as potential mediators of the relationship between genotype and fMRI activity.
B1475 - Time trends in child mental health problems - 06/12/2012
Background: An important question of public and policy concern is the extent to which mental health problems in young people has changed in prevalence over time. Diagnoses and treatment of problems such as autism, ADHD, and depression have shown substantial increases over recent decades, but changes may reflect changes in help seeking, clinical recognition and diagnostic practice. To address whether the population prevalence of child and adolescent mental health problems has changed comparison of unselected representative population cohorts is required (using comparable measures of mental health at each time).
Evidence of this kind shows that adolescent emotional and conduct problems have become increasingly common since the 1970s (Collishaw et 2004, 2010; Kosidou et al 2010; Sigfusdottir et al 2008; Sourander et al 2004; Sweeting et al 2009; Ticket et al 2008). These trends are important for service planning, as well as offering novel approaches to examining risk. Time changes in prevalence must be attributable to population-level changes in environmentally mediated risks. By contrast with findings in adolescence, there is a marked knowledge gap on trends in younger children's mental health. This is important as, knowing whether observed trends in adolecent mental health have their origins in childhood can help narrow down likely causal explanations. However, to date, findings on pre-adolescent children are limited and inconsistent (Achenbach et al 2003; McArdle et al 2003; Sourander et al 2008; Tick et al 2007).
Time trends research provides a method for identifying explanatory environmental risk at a population-level. Thus far, however, very few studies have attempted to go beyond documenting trends, and studies that have tested possible explanations have focused on adolescents (Collishaw et al 2007, 2011; Schepman et al 2011; Gore et al 2011; Sweeting et al 2010). It is important to examine whether population-level change in risk prevalence has contributed to change in child mental health problems.
It is also important to understand any consequences of changes in rates of child psychopathology. There is extensive evidence that mental health symptoms are associated with concurrent impairment and adverse later mental health and psychosocial outcomes (Green et al 2005; Costello et al 2011; Maughan & Kim-Cohen 2005; Scott et al 2001). To date, there has been very little attempt to investigate these associated features in studies of time trends, but it is important to do so, not least because it can provide further evidence of the validity of observed trends (Collishaw et al., 2004).
The project will capitalise on comparable assessments of the mental health (and related risk factors) in seven-year-olds across five UK population cohorts studied from 1965 to 2008 (NCDS, ALSPAC, BCAMHS99, BCAMHS04, MCS). Cross-cohort analyses of the type proposed here offer a unique opportunity to better understand changes in child mental health, and specifcally to address the following aims.
Aims
(1) To test trends in prevalence of child mental health problems over a 40-year period in the UK using comparable assessments of emotional, conduct, and ADHD problems.
(2) To test whether the prevalence and impact of pre-/peri-natal, neurodevelopmental and early psychosocial risks has changed and how such changes have contributed to child mental health trends.
(3) To test trends in the impact of child mental health problems on current functioning, and on later mental health and psychosocial adaptation (using the three longitudinal cohorts).
Hypotheses: Findings regarding trends in child mental health problems are inconsistent. However, it is hypothesised that any increases in symptom levels may be associated with rising rates of impairment and poorer later outcomes
Exposure variable(s)
(1) The primary 'exposure variable' with respect to aim 1 will be year of study.
(2) Exposure variables of interest with respect to aim 2 include
a) Pre- and peri-natal factors: gestational age, birth weight, prematurity, birth complications, maternal smoking in preganancy
b) Neurodevelopmental factors: neurological abnormalities, epilepsy, learning disabilities, language delay, chronic ill health
c) Early psychosocial factors: family composition, social disadvantage, early parental involvement
Outcome variable(s):
1) The primary outcome variable is the parent-rated Strength and Difficulties Questionnaire (SDQ) at age 7 years. This measure is available in three of the other cohorts. The predecessor of the SDQ (the Rutter A scale) will be used in NCDS with comparability ensured using calibration methods developed in our previous studies of time trends (Collishaw et al., 2004).
2) Additional outcomes of interest available in some (but not all) of the cohorts include the teacher SDQ at age 7, and later outcome data: SDQ at ages 11, 14 16 years; peer relations at age 11 and 16 years; school exam attainment/occupation at age 16 years.
Confounding variables: Predictors of non-response assessed at birth, child ethnic origin, child gender, child age (in months).
B1474 - Quantile Regression for Growth Curves - 06/12/2012
The aim of my research masters is to compare several different statistical methods of constructing reference growth curves for children's heights, weights and body mass index measurements.
I have no hypothesis as my project is exploratory, using real datasets to determine the performance of these statistical methods and to further expand my knowledge of these approaches.
I hope to construct a function for children's expected height measurements which incorporates their previous height history and their parental height measurements. This can then be used to determine if their current observed reading is as expected. Similar functions for the weight and body mass index measurements will also be constructed.
B1473 - The effects of interaction between 5-HTTLPR genotype and family environments on adolescent substance use - 06/12/2012
Underage drinking is pervasive in the U.S. For example, 39% of adolescents in grades 9 through 12 report to consume alcohol in the past month. Furthermore, problematic drinking behavior such as binge drinking (defined as consuming more than four drinks for women and five drinks for men in the past two weeks) and alcohol use disorders emerge in adolescence. Underage drinking brings long-term negative consequences such as permanent damage to brain development, later alcoholism and drug problems, and school drop-outs that affects later education and occupation. For adolescents, family environments such as family conflict and parental monitoring have been studied as risk factors for alcohol use and abuse. However, some people in those environments do not develop drinking problems while other do. Gene and environment interaction (GxE) studies could provide compelling explanations for this, demonstrating that an individual's genotypes strengthen or weaken their susceptibility to the environmental influences. Thus, this study will investigate the effect of interaction between one of a genotype (5-HTTLPR; serotonin transporter linked polymorphic region) and family environments (i.e., family conflict and parental monitoring) on adolescent alcohol use and related problems.
Using ALSPAC data, we will examine our hypothesis that individuals who have at least one short 5-HTTLPR allele and have experienced high levels of parental monitoring would be less likely to be involved in alcohol use than would individuals with only long 5-HTTLPR alleles in the same same environments. Also, we will examine whether individuals with at least one short 5-HTTLPR allele and have experienced high levels of family conflict would be more likely to be involved in alcohol use than would individuals with only long 5-HTTLPR alleles in the same environments. We will statistically control the effects of age, race, gender, puberty, the level of parents' education, and neighborhood context.
The implications of the potential findings are significant for prevention and intervention efforts to curtail prevalent alcohol use among adolescents. Results for the present study will provide information for specific family environments interacting with genetic risk to affect adolescent drinking problems. If family environments affect the relationship between 5-HTTLPR genetic risk and alcohol use in the way we have suggested, the findings will be useful in developing more effective prevention or intervention strategies designed to improve family environments for those individuals whose genotypes make them sensitive to those environments. Overall, the present study will contribute to our understanding of the etiology of adolescent alcohol use and the findings will be valuable for future research directions.
B1465 - EAGLE GWA meta-anaylsis on ADHD - 04/12/2012
The aim of the current study is to identify genetic variants that influence the risk of Attention Problems
and ADHD in children.
Previous genome-wide association studies on ADHD have not been able to establish genome-wide
significant results, indicating that effect sizes are probably small and that large sample-sizes are needed to
reliably identify genetic risk factors for ADHD, although othe explanations including phenotype
definitions are also possible.
To continue the search for genes underlying variation in Attention problems and ADHD, all cohorts
participating in the EArly Genetics and Lifecourse Epidemiology (EAGLE) Consortium are invited to
perform a genome-wide association analysis on attention problems, ADHD or ADHD-related traits, after
which a meta-analysis will take place. Both an analysis of a continous and a dichotomized trait will be
performed, on parent and teacher ratings of children seperately. Cohorts that do not have genome-wide
data are then invited to perform genotyping of the top SNPs in order to attempt to replicate the results
found in the discovery cohort.
B1460 - In-silico detection of deletions in KLK3 from the ALSPAC raw SNP data - 03/12/2012
Aim: To estimate the frequency of KLK3 copy number variants in the general population.
KLK3 encodes PSA, the most widely used biomarker in the early detection of prostate cancer. Genetic variants in KLK3 may influence serum PSA levels. From a pilot of selected controls within the ProtecT biorepository, we have identified three subjects with very low serum PSA levels (less than 1 ng/micro-L) with evidence of heterozygous deletions that entirely encompassed KLK3 (Rodriguez et al., Clinical Chemistry, in press)
Hypothesis: That deletions in the KLK3 region can be identified from SNP raw data available from ALSPAC.
Background: SNP arrays were originally designed to genotype SNPs; however they have been adapted for structural variant discovery. Several tools to analyse data from SNP arrays have been developed recently, however they tend to be platform-specific (i.e. able to process either Affymetrix or Illumina array data).
Algorithms that handle data from Affymetrix arrays include programmes as Birdsuite (1), and ITALICS (2). Other algorithms were developed to analyse data from Illumina arrays, such as SCIMM (3) and TriTyper (4). Some software applications are "versatile"; capable of handling data from both platforms (e.g.) PennCNV (5) and QuantiSNP (6).
Approach: Access to the fluorescence SNP raw data for a genomic interval of ~18Mb on chromosome 19 is required; (Chromosome 19: [41,000,000 - 59,128,983] Human GRCh37 build). This interval includes the entire human kallikrein locus, comprised of 15 kallikrein genes -in tandem-, including KLK3 that encodes the prostate specific antigen (PSA). Indeed serum PSA of normal women is typically undetectable (around 1 pg/mL) (7), however, deletions in KLK3 could be transmitted from mothers to children. KLK3 deletions from the general population, and from prostate cancer cases are considered. ALSPAC mothers will fit in as a "control" group to data from the 1958 cohort and from the ProtecT cohort (males with prostate cancer and controls). Copy number variants with high confidence scores will be assembled from multiple scans using several algorithms, filtering out false positive/discrepant signals in the process. A list of copy number variants called from this study will be compared across other studies to estimate the frequency of deletion events in KLK3 among males vs. females, and male controls vs. prostate cancer cases. We will also request access to the SNP genotype data for the same genomic region for children. This will enable us to study deletion transmission patterns from mothers to children.
References:
Santiago Rodriguez, Osama A Al-Ghamdi, Kimberley Burrows, Philip A.I. Guthrie, J. Athene Lane, Michael Davis, Gemma Marsden, Khalid K Alharbi, Angela Cox, Freddie C Hamdy, David E Neal, Jenny L Donovan, and Ian N. M. Day (2012) Very low PSA levels and deletions of the KLK3 gene. Clin Chem, -in press-.
(1) Korn, J. M., F. G. Kuruvilla, S. A. McCarroll, A. Wysoker, J. Nemesh, S. Cawley, E. Hubbell, J. Veitch, P. J. Collins, K. Darvishi, C. Lee, M. M. Nizzari, S. B. Gabriel, S. Purcell, M. J. Daly & D. Altshuler (2008) Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet, 40, 1253-60.
(2) Rigaill, G., P. Hupe, A. Almeida, P. La Rosa, J. P. Meyniel, C. Decraene & E. Barillot (2008) ITALICS: an algorithm for normalization and DNA copy number calling for Affymetrix SNP arrays. Bioinformatics, 24, 768-74.
(3) Kelley, D. R. & S. L. Salzberg (2010) Clustering metagenomic sequences with interpolated Markov models. BMC Bioinformatics, 11, 544.
(4) Franke, L., C. G. de Kovel, Y. S. Aulchenko, G. Trynka, A. Zhernakova, K. A. Hunt, H. M. Blauw, L. H. van den Berg, R. Ophoff, P. Deloukas, D. A. van Heel & C. Wijmenga (2008) Detection, imputation, and association analysis of small deletions and null alleles on oligonucleotide arrays. Am J Hum Genet, 82, 1316-33.
(5) Wang, K., M. Li, D. Hadley, R. Liu, J. Glessner, S. F. Grant, H. Hakonarson & M. Bucan (2007) PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res, 17, 1665-74.
(6) Colella, S., C. Yau, J. M. Taylor, G. Mirza, H. Butler, P. Clouston, A. S. Bassett, A. Seller, C. C. Holmes & J. Ragoussis (2007) QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res, 35, 2013-25.
(7) Chang, Y. F., S. H. Hung, Y. J. Lee, R. C. Chen, L. C. Su, C. S. Lai & C. Chou (2011) Discrimination of breast cancer by measuring prostate-specific antigen levels in women's serum. Anal Chem, 83, 5324-8.
B1472 - NMR metabolomics analysis of ALSPAC Child Mother and Fathers samples - 22/11/2012
The development of metabolomics research in population health science has been driven by mass spectrometry (MS) and proton nuclear magnetic resonance (NMR) spectroscopy as the two key experimental technologies. NMR spectroscopy is increasingly used because of its capability to simultaneously detect a wide range of metabolites, thus providing a "snapshot of the metabolite composition" in biofluids. NMR-based applications can also offer fully automated and highly reproducible high-throughput experimentation in a very cost-effective manner. During the last 5 years Prof Mika Ala-Korpela's Computational Medicine team has focused on developing an NMR metabolomics platform for analysing human serum - 1H NMR spectroscopy (Tukiainen et al 2008). This novel methodology has been used to analyse serum from over 100,000 individuals (in less than 4 years). The method uses three molecular windows, (two applied to native serum and one to serum lipid extracts requiring minimal preparation) to quantify the 216 metabolomic traits, including 14 lipoprotein subclasses with detailed molecular information on serum lipid extracts including free and esterified cholesterol, sphingomyelin, degree of saturation and omega-3 fatty acids, 117 metabolites (including 80 lipoproteins, 15 lipids and 22 low molecular weight metabolites), 99 derived metabolic measures indexing amino acid metabolism, gluconeogenesis, ketogenesis, kidney function, and fatty acid saturation, as well as measures such as apolipoprotein A-I and B (see list in Kettunen et.al 2012) . The majority of analyte data is reported as a molar concentration, with derived variables reported as ratios . 1H NMR spectroscopy-based quantification reduces measurement error for main blood lipid fractions, compared to the usual enzymatic methods, and also allows detection of associations with lipid and metabolic sub-phenotypes that may be proximal consequences of genetic variation and environmental risk factors.
Genome-wide associations with novel metabolic pathways are likely to be identified with greater statistical efficiency using phenotypes obtained from this method, and estimates from non-genetic association studies are also likely to be more precise. For example, in a GWAS of 8,330 adults using 216 serum metabolic phenotypes measured using 1H NMR spectroscopy 31 GWAS loci with p less than 10-10 were identified, 20 of which replicated previously known associations obtained in much larger sample sizes and 11 of which were novel(Kettunen et. al. 2012). In a second study of 9,179 adults, 6 novel metabolites associated with CVD mortality, which were independent of established risk factors, were identified. (al-hussaini et.al. 2012)
We plan to analyse all suitable plasma and serum samples collected from ALSPAC participants, their mothers and fathers at as many timepoints as possible. Methodology exists for analysis of EDTA plasma and serum samples from adults and children. Methodology will be developed for analysis of cord blood plasma and/or serum samples and may be developed for heparin plasma samples.
Data generated will become part of the ALSPAC resource and utalised for a numerous association studies which will be covered by separate applications to ALSPAC Executive.
Samples will initially be analysed in Prof Ala-Korpela's Computational Medicine laboratories,
University of Oulu & University of Eastern Finland (Kuopio), (details of first sets on samples in Appendix 1b below).
UoB has recently invested in core metabolomics facilities, including a new 500 MHz instrument NMR system 2, which will be overseen by Prof Ala-Korpela. In the future, analysis will be completed in these new UoB facilities.
Tukiainen T, Tynkkynen T, Makinen VP et al. A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease. Biochem Biophys Res Commun 2008;375:356-361
Kettunen J, Tukiainen T, Sarin AP et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 2012;44:269-276
al-hussaini A, Sehmi J, Tan T, Ala-Korpela M, Kooner J, Chambers J. Identification of novel metabolic biomarkers for cardiovascular mortality. Journal of the American College of Cardiology 2012;59:E1649-doi:10.1016/S0735-1097(12)61650-7
B1471 - Developmental origins of mood symptoms in children and adolescents The role of genes maltreatment and social process - 22/11/2012
SPECIFIC AIMS
This research proposal aims to identify mechanisms explaining why early adversity, namely child maltreatment, is consistently associated with an elevated risk for mental disorder 1-7. While there has been much emphasis on the long-term effects of adversity, including how genes and adversity jointly shape risk 8, there is limited research on how timing of adversity shapes trajectories of development and risk for internalizing symptoms.
The overarching concept we seek to test is that there are "sensitive periods" in development 9-11, or windows of time in the lifespan when the developing brain is particularly vulnerable or sensitive to experience, including adversity. Sensitive periods are characterized by phases of high plasticity and rapid brain development in a given domain 12; 13. First articulated by Hubel and Wiesel 14, a robust literature in animals 15; 16 and now in humans has identified sensitive periods in visual 17 and auditory system processes, including language development 18-22. Several genes (e.g., GAD1, GAD2, GABA1 alpha subunit, and BDNF) and environmental exposures (e.g., exercise, psychotropic medications) have been shown in animal studies to manipulate sensitive periods, either triggering their opening or closing 23. Importantly, recent literature also suggests sensitive periods are not fixed or limited solely to the early years of life and brain development. Instead, sensitive periods can be reopened throughout the lifecourse, even in adulthood, as a result of genetically-mediated factors and environments that "remove the brakes on plasticity" 24; 25.
Currently, we lack an in-depth understanding of the time-dependent effects of adversity on the Research Domain Criteria (RDoC) functional domains 26-29. This is especially true for social system processes, including attachment, social cognition, and social communication, which are likely precursors of internalizing symptoms. Although understudied, extant research suggests there are sensitive periods in attachment 30 and social cognition 31. Child abuse and neglect are known to affect social system processing, including perception of emotional expression32. However, it is unclear whether these effects are the same for all maltreated children or whether there is individual variation, depending on the age when children are first exposed. To that end, early evidence from epidemiological studies now suggests the effects of child maltreatment on internalizing symptoms differ depending on age at first exposure, which is suggestive of a sensitive period 33-35.
Based on prior research and our preliminary studies, the main hypothesis we are testing is that disruptions in social system processes explain the elevated risk of internalizing symptoms among children exposed to maltreatment and that the magnitude of this relationship will depend on the developmental timing of exposure to adversity and what sets of genes are expressed at that point in time.
HYPOTHESES
This proposal will test the following aims/hypotheses:
Aim 1: Explore the time-dependent effect of maltreatment on social domains/internalizing symptoms
Hypothesis 1: Children exposed to maltreatment during a sensitive period (age 3-5) will have lower functioning in social system domains and higher internalizing symptoms when compared to both non-exposed children and children exposed outside of the sensitive period, even after adjusting for maltreatment features (e.g., duration).
Aim 2: Examine the association between age at first onset of exposure to child maltreatment, social function, and internalizing symptoms in adolescents
Hypothesis 2: Social functioning will partially mediate or explain the association between age at first onset of exposure to child maltreatment and internalizing symptoms.
Aim 3: Investigate whether developmental genes modify the association between age at first exposure to child maltreatment and both social domain functioning and internalizing symptoms
Hypothesis 3: Variants in genes shown in animal studies to regulate sensitive periods, and sets of genes shown in humans to be differentially expressed across the lifespan, will modify the effect of adversity timing on domains of social functioning and internalizing symptoms.
The expected outcome of this proposal will be the development of a more nuanced approach to defining sensitive periods and the time-dependent effects of adversity on domains relevant to RDoC. This knowledge will have major impacts on the field, including greater insights into the biology of and mechanisms explaining susceptibility to internalizing symptoms and lead to the development of novel preventions and treatments.
EXPOSURE VARIABLES
Caregiver Reported Childhood Adversities: At yearly intervals between ages 1 and 8, caregivers provided information about whether the child was exposed to the different adversities in the past 12 to 18 months, including being taken into some form of foster care; physically hurt by someone else; sexually abused; separated from mother; and separated from father. This was included in the section entitled "Upsetting Events."
Child Reported Childhood Adversity: At age 16 children were asked to report whether they had been exposed to 23 different types of stressors since age 12.
Documented Reports of Child Maltreatment: We are also seeking information from the 329 children who were invested by social services for suspected maltreatment prior to age 6; this includes 162 children who were placed on local child protection registries as having confirmed cases of maltreatment.
MEDIATOR VARIABLES
Diagnostic Assessment of Non-Verbal Accuracy (DANVA): We are requesting data from the DANVA, which provides information about the offspring's ability to accurately detect facial displays of emotion. This task was administered at age 8.
Emotion Triangles Task: The child's ability to attribute emotional states to other individuals, a component of theory of mind, was assessed at age 13, using the emotion triangle task.
Separation Anxiety, as measured by the Development and Wellbeing Assessment (DAWBA), was asssessed at ages 7, 10, 13, 15.
Social and Communication Disorders Checklist: We are requesting data from this measure, which taps domains of social cognition. It appears this measure was administered to children at ages 7 and 15 (and possibly 10 and 13).
OUTCOME VARIABLES
We are proposing to examine the following outcome variables: (1) Rutter parent scale for preschool children; (2) Strengths and difficulties questionnaire; (3) Development and Wellbeing Assessment; (4) Short Mood and Feelings Questionnaire. For all of these outcomes, we will examine symptoms of mood and anxiety disorders (as a continuous measure) as well as extremes in the symptom distribution or diagnoses (from DAWBA).
EFFECT MODIFIERS
We are proposing to examine sets of genes as effect modifiers of the association between maltreatment and both social system processing and mood and anxiety disorders. Please see Appendix 1B for further details on the genetic information we are requesting.
COVARIATES
We would also be interested in receiving basic demographic variables to use as covariates in our analysis. This includes information about: age, gender, race/ethnicity, socioeconomic status.
B1470 - Investigation of the mapping from genetic markers to facial features - 22/11/2012
Aim: we aim to investigate the mapping from genetic variants to normal facial variation measures using data from the Avon Longitudinal Study of Parents and Children (ALSPAC). 3D high-resolution images have been obtained using two laser scanners for 4747 children. The images were merged, aligned and 22 important facial landmarks were identified. Their x, y and z co-ordinates were used to generate 54 3D distances reflecting facial features. These children also have genome-wide single nucleotide polymorphism (SNP) data available for ~2.5 million genetic markers.
Dr. Campbell has a long standing interest in machine learning and the posed problem of mapping from genetic data to a set of facial feature measures is a classic problem within machine learning. We will start by looking at some Bayesian ARD algorithms, previously devised by Dr. Campbell and collaborators (ARD = automatic relevance determination). These algorithms have an inbuilt mechanism to discard features (in this case genetic variant data) irrelevant to the considered problem. They derive a regression function (since the mapped facial feature will be continuously-valued). Performance evaluation will be on test data by ranked performance i.e. we make a prediction from the input data, evaluate the distance between this prediction and the corresponding facial feature measures of members of the test group, hence determining the position of the correct matching value in the rank list. For n members of the test set, an average rank of n/2 indicates null predictive performance. We will experiment with other types of classifier and other feature selection strategies, including predictors which give a posterior spread for the prediction (a mode and a spread for the predicted facial features). We also aim to look at other machine learning tools, for example, sparseCCA (canonical correlation analysis) which may indicate the correlates between sets of input (genetic) features and facial features.
Dr. Campbell has already contacted Dr. Lavinia Paternoster (MRC CAiTE centre) and will work closely with her and the rest of the team generating and analysing this data. We only envisage an initial look-see investigation to determine the level of predictive performance which may be achievable. It is possible the size of the input data (~2.5 million genetic markers) may be too prohibitive in computational cost for the anticipated Bayesian ARD algorithms. Also predictive performance may be too low. However, should positive results be obtained, we will communicate this to Lavinia and collaborators to discuss extensions and any possible scope for publications.
B1469 - Long-term effects of infant sleeping position - 22/11/2012
Aims: To determine whether sleeping position in the first 6 months is associated with long-term phenotypic changes.
Hypotheses:
1. That there is no adverse association of long-term physical health associated with sleeping on the back or side.
2. That a consequence of increased risk of chest infection associated with prone sleep position is a reduction in lung function in childhood.
3. That prone sleeping may be associated with improved motor ability and coordination.
4. That sleeping position has no long-term effect on cognitive abilities, behaviour or educational attainment.
Exposure variables:
Sleeping position, and other features of bedding and parenting up to 18 months
Outcome variables
All phenotypes on the database
Confounding variables
Gender; socio-economic features; housing; diet; parental education; child care; birthweight; gestation; etc.
Statistical approach will use a phenome scan, taking account of multiple testing. Regression analyses will be used to account for confounders as appropriate.
B1468 - The causal role of the nutritionally-regulated IGF system in prostate cancer Mendelian randomization study - 22/11/2012
Background:
The main component of this investigation is based in the ProtecT prostate cancer trial, co-ordinated from the School of Social and Community Medicine. This study is funded by a World Cancer Research Fund grant. We are applying to use ALSPAC data in order to conduct a validation exercise, and to perform a genome-wide association study (GWAS).
The nutritionally-regulated insulin-like growth factor (IGF) system, which includes two IGFs (IGF-I and IGF-II) and six IGF-binding proteins (IGFBP-1 to -6) play a key role in somatic growth, and activate potentially carcinogenic intracellular signalling networks. Many epidemiological studies observe positive associations of circulating IGF-I with prostate cancer but our recent systematic review highlights inconsistencies,[1] and it is unclear whether elevated IGF-I causes prostate cancer or reflects confounding or reverse causality. We have completed the largest single study we are aware of to investigate IGFs/IGFBPs in prostate cancer (ProtecT study), revealing strong positive associations of IGF-II, IGFBP-2 and IGFBP-3 with screen-detected prostate cancer (all p trendless than 0.001) but no association of serum IGF-I.[2] Our findings are consistent with other much smaller investigations for IGF-II, IGFBP-2 and IGFBP-3, but causality remains to be established.
Recently discovered genetic associations with prostate cancer are linked to the IGF-signalling pathway. In a genome-wide association study (GWAS),[3] 4 of 7 genotypes linked to prostate cancer are also involved in the IGF system: homozygous variants at insulin-IGF2 and NKX3.1 (an androgen-regulated tumour suppressor gene that regulates IGFBP-3) had up to a 50% increased prostate cancer risk, while homozygous variants at ITGA6 (encodes integrins that interact with IGFBPs) and PDLIM5 (inter-connected to an IGF-1R signaling protein that regulates migration) had up to a 65% decreased risk. Other common IGF-related genes (e.g. IGF-1R; PI3K; INS; IRS-1/-2) are associated with prostate or other cancers.[4-9]
Some genotypes are, simultaneously, related to both IGF/IGFBP levels and cancer; e.g. men homozygous for IGFBP-3 -202A/C promoter variants have lower circulating IGFBP-3,[10] a 2.5-fold increased prostate cancer risk[11] and a four-fold increased risk of metastatic disease.[12] IGF-1-variants are associated with both circulating IGF-I[8] and prostate (OR=1.46) [8] and breast (OR=1.4) [13] cancer; IGFBP-3 rs2270628 is associated with IGF-I and ovarian cancer (ORs=1.18-1.36).[14] There are very few studies relating genetic variants to IGF-II or IGFBP-2 levels. One GWAS relating genetic loci to circulating IGF-I and IGFBP-3 has been carried out in middle-aged adults, and identified several loci that were associated with IGFBP-3 and IGF-I concentrations.[15].
Aims:
We aim to clarify the role of the IGF system in prostate cancer, by using genetic variants as 'instruments' for measured circulating IGF-I, IGF-II, IGFBP-2 and IGFBP-3 and conducting formal Mendelian randomization (MR) instrumental variables (IV) analyses to obtain causal (unconfounded and unbiased) odds ratios for associations of circulating IGFs/IGFBPs with prostate cancer initiation and progression. Application of MR will identify IGFs/IGFBPs that are causally important in prostate cancer initiation or progression, which could be manipulated for primary or secondary prostate cancer prevention. Some trials of dietary interventions to reduce IGFs/IGFBPs in men at high risk of cancer are already underway, but should only be warranted if a causal link is demonstrated, particularly given potential unintended IGF-related effects (e.g. on insulin resistance, cardiovascular disease and cognitive decline). If we determine, instead, that raised IGFs/IGFBPs are a consequence of prostate cancer (reverse causality), the focus of future research would shift to assessing these ligands as nutritionally-related biomarkers of diagnosis or cancer monitoring/surveillance.
Objectives:
1) To obtain unbiased estimates of the diection and magnitude of the the causal associations of circulating IGF-I, IGF-II, IGFBP-2 and IGFBP-3 with prostate cancer prevalence, stage and grade, and disease progression. This will involve i) deriving genetic allele scores based on single nucleotide polymorphisms (SNPs) associated with IGF/IGFBP levels, in approximately 1000 controls from the ProtecT prostate cancer cohort; ii) validating the allele scores in ASLPAC children (or deriving new allele scores if we observe differences in SNP-IGF associations in adults versus children).
2) To conduct a genome-wide association study to identify SNPs associated with circulating IGF-I, IGF-II, IGFBP-2 and IGFBP-3 during childhood, among children in ALSPAC.
Hypothesis:
Raised levels of circulating IGF-I, IGF-II, IGFBP-2 and IGFBP-3 are causally associated with increased risk of prostate cancer overall; advanced stage and grade; and with disease progression.
Exposure:
GWAS (which will include selected variants in IGF-related genes)
Outcome:
Circulating IGF-I, IGF-II, IGFBP-2 and IGFBP-3 levels in all children in whom it was measured.
Confounding variables:
Age at time of IGF/IGFBP measurement, sex, 10 principal components for population stratification.
Reference List
1 Rowlands M, Gunnell D, Harris R, Vatten LJ, Holly JMP, Martin RM: Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis. Int J Cancer 2009;124:2416-2429.
2 Rowlands MA, Holly JMP, Gunnell D, Donovan J, Lane JA, Hamdy F, Neal DE, Oliver S, Smith GD, Martin RM: Circulating Insulin-Like Growth Factors and IGF-Binding Proteins in PSA-Detected Prostate Cancer: The Large Case-Control Study ProtecT. Cancer Res 2012;72:503-515.
3 Eeles RA, Kote-Jarai Z, Al Olama AA, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009;41:1116-1121.
4 Schumacher FR, Cheng I, Freedman ML, et al. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet 2010;19:3089-3101.
5 Koutros S, Schumacher FR, Hayes RB, et al. Pooled Analysis of Phosphatidylinositol 3-Kinase Pathway Variants and Risk of Prostate Cancer. Cancer Res 2010;70:2389-2396.
6 Neuhausen SL, Slattery ML, Garner CP, Ding YC, Hoffman M, Brothman AR: Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk. Prostate 2005;64:168-174.
7 Ho GY, Melman A, Liu SM, Li M, Yu H, Negassa A, Burk RD, Hsing AW, Ghavamian R, Chua SC, Jr.: Polymorphism of the insulin gene is associated with increased prostate cancer risk. British Journal of Cancer 88(2):263-9, 2003.
8 Johansson M, Mckay JD, Stattin P, Canzian F, Boillot C, Wiklund F, Adami HO, Balter K, Gronberg H, Kaaks R: Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer. Int J Cancer 2007;120:539-542.
9 Cheng I, Stram DO, Penney KL, Pike M, Le ML, Kolonel LN, Hirschhorn J, Altshuler D, Henderson BE, Freedman ML: Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort. J Natl Cancer Inst 2006;98:123-134.
10 Gu F, Schumacher FR, Canzian F, Allen NE, et al. Eighteen Insulin-like Growth Factor Pathway Genes, Circulating Levels of IGF-I and Its Binding Protein, and Risk of Prostate and Breast Cancer. Cancer Epidemiology Biomarkers & Prevention 2010;19:2877-2887.
11 Hernandez W, Grenade C, Santos ER, Bonilla C, Ahaghotu C, Kittles RA: IGF-I and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Carcinogenesis 2007;28:2154-2159.
12 Wang LZ, Habuchi T, Tsuchiya N, et al. Insulin-like growth factor-binding protein-3 gene-202 A/C polymorphism is correlated with advanced disease status in prostate cancer. Cancer Res 2003;63:4407-4411.
13 Al-Zahrani A, Sandhu MS, Luben RN, et al. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 2006;15:1-10.
14 Terry KL, Tworoger SS, Gates MA, Cramer DW, Hankinson SE: Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk. Carcinogenesis 2009;30:2042-2046.
15 Kaplan RC, Petersen AK, Chen MH, et al. A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. Hum Mol Genet 2011.
B1467 - Does TRPA1 modify the effects of prenatal paracetamol and tobacco smoke exposure on childhood respiratory outcomes - 22/11/2012
Background:
We have previously reported an association between prenatal paracetamol exposure and asthma in ALSPAC and shown that this relation is modified by maternal antioxidant gene polymorphisms [1,2]. It was recently reported that the analgesic properties of paracetamol may be mediated by the transient receptor potential ankyrin-1 (TRPA1) channel [3]. Furthermore, animal studies have suggested that TRPA1 plays a role in airway inflammation in asthma [4] and, of relevance to our epidemiological observations, there is evidence that paracetamol can cause neurogenic inflammation in the airways through stimulation of TRPA1 [5]. Cigarette smoke induced neurogenic inflammation is also thought to be mediated by TRPA1 [6].
Aims:
To analyse the relation between maternal and child TRPA1 variants and asthma and lung function in ALSPAC and to explore interactions between TRPA1 and prenatal paracetamol and tobacco smoke exposure on childhood asthma and lung function in order to potentially strengthen causal inference and shed light on mechanisms.
Hypotheses:
1) Maternal and child TRPA1 genotype is associated with asthma and lung function in the offspring.
2) TRPA1 modifies the effects of prenatal paracetamol exposure on childhood asthma and of maternal smoking in pregnancy on childhood small airway function.
Analyses:
It has been proposed that TRPA1 alleles in ALSPAC could be inferred using SNP imputation; a list of 129 imputed SNPs has been generated (all SNPs except one which have been mentioned in the literature associated with pain phenotypes are included in this list) and the plan is to work with Dave Evans to see how best to analyse the data.
A DTA covering analysis of genetic data is already in place with QMUL.
NB: We have all other variables (maternal exposures, confounders and childhood atopic and respiratory outcomes) needed to carry out these analyses.
References:
1) Shaheen SO, Newson RB, Henderson AJ, Headley JE, Stratton FD, Jones RW, Strachan DP, and the ALSPAC Study Team. Prenatal paracetamol exposure and risk of asthma and elevated IgE in childhood. Clin Exp Allergy 2005; 35:18-25.
2) Shaheen SO, Newson RB, Rose-Zerilli M, Ring SM, Holloway JW, Henderson AJ. Prenatal and infant acetaminophen exposure, antioxidant gene polymorphisms and childhood asthma. J Allergy Clin Immunol 2010; 126: 1141-1148.
3) Andersson DA et al. TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid delta9-tetrahydrocannabiorcol. Nature Communications 2011; 2:551.
4) Caceres AI et al. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. PNAS 2009; 106: 9099-9104.
5) Nassini R et al. Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. FASEB J 2010; 24:4904-16.
6) Andre E et al. Cigarette smoke-induced neurogenic inflammation is mediated by alpha, beta-unsaturated adehydes and the TRPA1 receptor in rodents. J Clin Invest 2008; 118: 2574-82.